BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4836147)

  • 1. Malignant hyperthermia in a family: a clinical and serological investigation of 139 members.
    Kelstrup J; Reske-Nielsen E; Haase J; Jorni J
    Acta Anaesthesiol Scand; 1974; 18(1):58-64. PubMed ID: 4836147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant hyperthermia following nitrous oxide-halothane anesthesia].
    Stovner J; Sundt T; Mohr B; Lilleaasen P
    Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1512-6. PubMed ID: 1179364
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hyperpyrexia in Australia and New Zealand.
    King JO; Denborough MA
    Med J Aust; 1973 Mar; 1(11):525-8. PubMed ID: 4699727
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia due to general anesthesia. Diagnosis and treatment].
    Böttger P; Doehn M; Horatz K; Kessler G
    Anasthesiol Intensivmed Prax; 1975; 10(1):13-6. PubMed ID: 1163751
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant hyperpyrexia: Investigation of a family after a fatal case.
    Ryan DW; Appleyard TN
    Br J Anaesth; 1975 Sep; 47(9):1001-4. PubMed ID: 1191461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia in a family.
    Kelstrup J; Haase J; Jorni J; Reske-Nielsen E; Hanel HK
    Acta Anaesthesiol Scand; 1973; 17(4):283-4. PubMed ID: 4272689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum myoglobin levels following administration of succinylcholine during nitrous oxide-oxygen-halothane anesthesia (author's transl)].
    Inagaki M; Koyama A; Sakata S; Tonogai R; Yamada Y; Kawai H; Iwasa M; Kondo A; Miyoshi K
    Masui; 1980 Nov; 29(12):1476-82. PubMed ID: 7463707
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperpyrexia and the dental outpatient.
    Wedley JR; Jaffe EC
    Anaesthesia; 1973 Mar; 28(2):146-54. PubMed ID: 4696355
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant hyperthermia.
    Brown LL; Britt BA
    South Med J; 1974 Jul; 67(7):799-804. PubMed ID: 4834737
    [No Abstract]   [Full Text] [Related]  

  • 10. Suspected malignant hyperthermia in a strabismus patient. A case report.
    Dodd MJ; Phattiyakul P; Silpasuvan S
    Arch Ophthalmol; 1981 Jul; 99(7):1247-50. PubMed ID: 7259598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia.
    Brockhouse RT
    J Am Dent Assoc; 1979 Apr; 98(4):581-3. PubMed ID: 285135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia associated with enflurane anesthesia.
    Caropreso PR; Gittleman MA; Reilly DJ; Patterson LT
    Arch Surg; 1975 Dec; 110(12):1491-3. PubMed ID: 1200833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant hyperthermia. III. Progress report on serum CK activity, questionable screening test, effect of dantrolene in family members with a hereditary disposition].
    Plötz J
    Anaesthesist; 1983 Apr; 32(4):158-64. PubMed ID: 6881517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant hyperthermia. Report of a case].
    Marín Ruiz R; Zepeda J
    Ginecol Obstet Mex; 1983 Sep; 51(317):241-4. PubMed ID: 6681307
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central core disease associated with malignant hyperthermia sensitivity].
    Krivosic-Horber R; Krivosic I
    Presse Med; 1989 Apr; 18(16):828-31. PubMed ID: 2524766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations.
    Lewandowski KB
    Br J Anaesth; 1981 Sep; 53(9):981-4. PubMed ID: 7284224
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and inheritance of malignant hyperthermia.
    Kalow W; Britt BA; Chan FY
    Int Anesthesiol Clin; 1979; 17(4):119-39. PubMed ID: 391720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant hyperthermia during an operation (a review of the literature)].
    Chernokozhev Kh
    Khirurgiia (Sofiia); 1976; 29(1):64-9. PubMed ID: 772294
    [No Abstract]   [Full Text] [Related]  

  • 19. Gly341Arg mutation indicating malignant hyperthermia susceptibility: specific cause of chronically elevated serum creatine kinase activity.
    Monsieurs KG; Van Broeckhoven C; Martin JJ; Van Hoof VO; Heytens L
    J Neurol Sci; 1998 Jan; 154(1):62-5. PubMed ID: 9543323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperpyrexia.
    Ellis FR
    Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.